Prudential Financial’s Vera Therapeutics VERA Stock Holding History

Prudential Financial’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Sell	10,520 -10,170	-49%	-$379K	﹤0.01%	1950
2026 Q1	$832K	Buy	+20,690	New	+$891K	﹤0.01%	1663
2025 Q3	–	Sell	-62,037	Closed	-$1.46M	–	2534
2025 Q2	$1.46M	Sell	62,037 -21,540	-26%	-$484K	﹤0.01%	1514
2025 Q1	$2.01M	Buy	83,577 +500	+0.6%	+$16.1K	﹤0.01%	1285
2024 Q4	$3.51M	Buy	83,077 +20,880	+34%	+$924K	﹤0.01%	1009
2024 Q3	$2.75M	Buy	62,197 +13,085	+27%	+$497K	﹤0.01%	1294
2024 Q2	$1.78M	Buy	+49,112	New	+$1.95M	﹤0.01%	1498

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Prudential Financial's VERA Position: Q2 2026 in Review

Prudential Financial reduced its Vera Therapeutics (VERA) stake by 49% in Q2 2026, selling an estimated $379K and leaving 10,520 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Prudential Financial first reported a position in VERA in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.51M in Q4 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Prudential Financial held 10,520 shares of Vera Therapeutics worth $451K as of Q2 2026.
Prudential Financial sold 10,170 Vera Therapeutics shares in Q2 2026, an estimated $379K.
Vera Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1950 holding.
Prudential Financial first reported a position in Vera Therapeutics in Q2 2024 and has held it in 7 quarters since.
Prudential Financial's Vera Therapeutics position peaked at $3.51M in Q4 2024.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.